Skip to Content



Definition: An oral antineoplastic agent that acts as a covalent inhibitor of Bruton tyrosine kinase; used in B-cell malignancies.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.